Haw Par Corporation Limited (HAWPF)
OTCMKTS · Delayed Price · Currency is USD
10.62
0.00 (0.00%)
Aug 6, 2025, 8:00 PM EDT
The Aaron's Company Revenue
In the year 2024, Haw Par Corporation had annual revenue of 244.82M SGD with 5.50% growth. Haw Par Corporation had revenue of 126.70M in the half year ending December 31, 2024, with 46.37% growth.
Revenue
244.82M SGD
Revenue Growth
+5.50%
P/S Ratio
13.55
Revenue / Employee
411.47K SGD
Employees
595
Market Cap
2.43B USD
Revenue Chart
* This company reports financials in SGD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 244.82M | 12.76M | 5.50% |
Dec 31, 2023 | 232.06M | 49.97M | 27.44% |
Dec 31, 2022 | 182.09M | 40.91M | 28.98% |
Dec 31, 2021 | 141.18M | 30.15M | 27.15% |
Dec 31, 2020 | 111.03M | -132.96M | -54.49% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Spruce Biosciences | 2.91M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |